Display options
Share it on

Int J Fertil Steril. 2016 Apr-Jun;10(1):62-70. doi: 10.22074/ijfs.2016.4770. Epub 2016 Apr 05.

Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran.

International journal of fertility & sterility

Leili Moezzi, Zeinab Keshavarz, Reza Ranjbaran, Farzaneh Aboualizadeh, Abbas Behzad-Behbahani, Masooma Abdullahi, Amin Ramezani, Alamtaj Samsami, Sedigheh Sharifzadeh

Affiliations

  1. Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
  2. Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  3. School of Advanced Medical Science and Technology, Shiraz University of Medical Sciences, Shiraz, Iran.
  4. Department of Obstetrics and Gynecology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 27123202 PMCID: PMC4845531 DOI: 10.22074/ijfs.2016.4770

Abstract

BACKGROUND: Maternal-fetal RhD antigen incompatibility causes approximately 50% of clinically significant alloimmunization cases. The routine use of prophylactic anti-D immunoglobulin has dramatically reduced hemolytic disease of the fetus and newborn. Recently, fetal RHD genotyping in RhD negative pregnant women has been suggested for appropriate use of anti-D immunoglobulin antenatal prophylaxis and decrease unnecessary prenatal interventions.

MATERIALS AND METHODS: In this prospective cohort study, in order to develop a reliable and non-invasive method for fetal RHD genotyping, cell free fetal DNA (cffD- NA) was extracted from maternal plasma. Real-time quantitative polymerase chain reaction (qPCR) for detection of RHD exons 7, 5, 10 and intron 4 was performed and the results were compared to the serological results of cord blood cells as the gold standard method. SRY gene and hypermethylated Ras-association domain family member 1 (RASSF1A) gene were used to confirm the presence of fetal DNA in male and female fetuses, respectively.

RESULTS: Out of 48 fetuses between 8 and 32 weeks (wks) of gestational age (GA), we correctly diagnosed 45 cases (93.75%) of RHD positive fetuses and 2 cases (4.16%) of the RHD negative one. Exon 7 was amplified in one sample, while three other RHD gene sequences were not detected; the sample was classified as inconclusive, and the RhD serology result after birth showed that the fetus was RhD-negative.

CONCLUSION: Our results showed high accuracy of the qPCR method using cffDNA for fetal RHD genotyping and implicate on the efficiency of this technique to predict the competence of anti-D immunoglobulin administration.

Keywords: Cell-Free Fetal DNA; Prenatal Diagnosis; Real-Time Polymerase Chain Reaction

References

  1. PLoS One. 2013 Oct 18;8(10):e76990 - PubMed
  2. Lancet. 1998 Oct 10;352(9135):1196 - PubMed
  3. Prenat Diagn. 2007 May;27(5):415-8 - PubMed
  4. PLoS One. 2012;7(9):e45073 - PubMed
  5. Transfus Med Hemother. 2013 Feb;40(1):37-43 - PubMed
  6. Methods Mol Biol. 2009;496:143-57 - PubMed
  7. Fetal Diagn Ther. 2005 Jul-Aug;20(4):275-80 - PubMed
  8. Ann N Y Acad Sci. 2006 Sep;1075:123-9 - PubMed
  9. Prenat Diagn. 2011 Aug;31(8):802-8 - PubMed
  10. Genet Mol Res. 2011 Oct 26;10(4):2653-7 - PubMed
  11. Transfusion. 2005 Mar;45(3):293-4 - PubMed
  12. PLoS One. 2013 Aug 06;8(8):e70984 - PubMed
  13. Placenta. 2004 Apr;25 Suppl A:S93-S101 - PubMed
  14. Clin Chem. 2006 Dec;52(12):2211-8 - PubMed
  15. Hum Genet. 2012 Jul;131(7):1205-16 - PubMed
  16. Transfus Clin Biol. 2006 Mar-Apr;13(1-2):53-7 - PubMed
  17. Transfusion. 2002 Aug;42(8):1079-85 - PubMed
  18. N Engl J Med. 1998 Dec 10;339(24):1734-8 - PubMed
  19. Transfus Clin Biol. 2007 Dec;14(6):572-7 - PubMed
  20. Clin Chem. 1999 Nov;45(11):2033-5 - PubMed
  21. Transfus Apher Sci. 2002 Dec;27(3):217-23 - PubMed
  22. Exp Mol Pathol. 2010 Dec;89(3):241-7 - PubMed
  23. Mol Diagn. 2004;8(1):23-31 - PubMed
  24. BMC Genet. 2001;2:10 - PubMed
  25. Am J Obstet Gynecol. 2005 Mar;192(3):666-9 - PubMed
  26. Med J Aust. 2009 Jul 6;191(1):21-5 - PubMed
  27. Pathology. 2012 Feb;44(2):69-72 - PubMed
  28. Clin Chem. 2000 Dec;46(12):1903-6 - PubMed
  29. Transfusion. 2012 Apr;52(4):752-8 - PubMed
  30. Blood. 2000 Jan 1;95(1):12-8 - PubMed
  31. Ann N Y Acad Sci. 2006 Sep;1075:308-12 - PubMed
  32. Prenat Diagn. 2003 Mar;23(3):235-8 - PubMed
  33. Curr Genet Med Rep. 2013 Mar 17;1(2):113-121 - PubMed
  34. Lancet. 1997 Aug 16;350(9076):485-7 - PubMed
  35. Transfusion. 2005 Sep;45(9):1473-80 - PubMed
  36. Prenat Diagn. 2007 Sep;27(9):824-9 - PubMed
  37. Eur J Clin Invest. 2009 Jul;39(7):607-17 - PubMed
  38. Transpl Immunol. 2005 Aug;14(3-4):143-53 - PubMed
  39. Blood. 1997 Apr 1;89(7):2568-77 - PubMed

Publication Types